TGFB1 and idiopathic pulmonary fibrosis: It also inhibits the generation and activity of fibrosis-related cytokines TGF-β1, fibronectin, and connective tissue growth factor, thus exerting anti-inflammatory and anti-fibrosis effects that have been regarded to treat IPF [8, 23–25].